Newsletter

207940 - Samsung Biologics Co., Ltd.

207940 Summary
Biopharma
Stock Price & Overview
₩1,447,000 -30,000 (-2.03%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩1,447,000  ≈ US$1,034  ·  Market cap ₩67.0tn (≈ $47.8bn)
What kstock analysis is. It reads the Korean news and the DART filing, checks the numbers against the source, and explains what changed and what to watch. It does not issue buy, sell or hold ratings and it does not set price targets. Why not »

207940 Analysis

ks

Samsung Biologics: The Eight-Year Plan Costs Less Per Year Than It Already Earns

Samsung Biologics Co., Ltd. laid out a ₩15.4tn investment plan running to 2034 this week, and the shares fell 2% on September 4 to ₩1,447,000, a ₩67 trillion market cap.

kstock researchToday, 11:02 AMCDMOSave
ks

Samsung Biologics Asks Shareholders For ₩3tn Five Weeks After Saying It Would Borrow

Samsung Biologics' board approved a ₩3,000.9bn rights offering on 28 August, issuing 2,270,000 new shares against 46,290,951 already outstanding.

kstock researchAug 28, 4:16 PMRights offeringSave
ks

Samsung Biologics: The Spin-Off Left A Better Company And An Unusable Track Record

Samsung Biologics' total assets fell from ₩18,337.3bn to ₩11,060.7bn across the fourth quarter of 2025 as Samsung Bioepis left the consolidation.

kstock researchAug 28, 4:03 PMSpin-offSave
ks

Samsung Biologics: ₩2.7tn For A Swiss Peptide Maker With Three Years Of Losses

Samsung Biologics is tendering for all of PolyPeptide Group AG at CHF 44.31 a share, about ₩2,706.2bn, or 36.3% of its own equity.

kstock researchAug 28, 4:00 PMM&ASave
4 pieces. Written with AI assistance from Korean-language sources; each links the article it rests on.

Similar to 207940

SymbolLast Price
068270Celltrion, Inc.₩188,100
+0.5%
196170Alteogen Inc.₩288,500
+1.9%
326030SK biopharmaceuticals Co., Ltd.₩86,600
+0.2%
128940Hanmi Pharm. Co., Ltd.₩473,500
+2.8%
000100Yuhan Corporation₩81,400
+0.0%
028300HLB Co., Ltd.₩33,750
+2.9%
298380ABL Bio Inc.₩71,400
+5.6%
000250Samchundang Pharm₩157,000
+1.0%
087010Peptron, Inc.₩157,300
+7.3%
141080LigaChem Biosciences Inc.₩92,000
+4.2%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.